Search
for

    Sort by

    Research 91–120 of 100

    1. Synopsis: 2005 Annual Meeting of the American Society of Andrology Journal of Andrology · 2005 · 1 citations
    2. Dihydrotestosterone and 5α-Reductase Humana Press eBooks · 2003
    3. Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent HAMDAN MEDICAL JOURNAL · 2021
    4. Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers Cancers · 2022 · 10 citations
    5. IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study Urology · 2023 · 2 citations
    6. Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis The World Journal of Men's Health · 2019 · 4 citations
    7. Pharmacogenetics of the Androgen Metabolic Pathway 2010
    8. Reply by the authors Urology · 2004
    9. 309 DOES VARIATION IN EITHER AGE AT START OF THERAPY OR DURATION OF THERAPY MAKE CHEMOPREVENTION WITH FINASTERIDE COST-EFFECTIVE? The Journal of Urology · 2011
    10. ENZYMES British journal of pharmacology · 2011 · 1 citations
    11. PCPT Results Could Affect Trial on Testosterone Replacement Oncology Times · 2003
    12. 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review BJUI · 2010 · 44 citations
    13. Étude PCPT : les biais attendus et leur gestion Progrès en Urologie · 2008 · 1 citations
    14. Alcohol and Prostate Cancer: Time to Draw Conclusions Biomolecules · 2022 · 9 citations
    15. Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention Journal of Clinical Oncology · 2009 · 6 citations
    16. A cornerstone of hematological science Community oncology · 2012
    17. Urological Oncology: Prostate Cancer The Journal of Urology · 2008
    18. Gleason grading controversies: what the chemoprevention trials have taught us Canadian Urological Association Journal · 2013 · 4 citations
    19. L'etude PCPT : regards d'un urologue intéressé Annales d Urologie · 2004
    20. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    21. Biomarker-based methods for determining noncompliance in a prevention trial Controlled Clinical Trials · 2002 · 11 citations
    22. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    23. Adherence with protocol medication use and mortality from unrelated causes in a prevention trial Preventive Medicine · 2021 · 1 citations
    24. Level-1 Data From the REDUCE Study and the PCPT Data Prostate Cancer · 2015
    25. THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatologic Therapy · 2010 · 9 citations
    26. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II Mayo Clinic Proceedings · 2006 · 2 citations
    27. Moving Chemoprevention Forward into the Most Promising Areas of Study Oncology Times · 2003
    28. Editorial Comment Urology · 2010
    29. Finasteride en el año 2006 Revista Argentina de Urología · 2006
    30. Editorial comment 1 Urology · 2004